amphetamine has been researched along with rg 1678 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alberati, D; Borroni, E; Hainzl, D; Hauser, N; Knoflach, F; Lengyel, J; Moreau, JL; Mory, R; Pinard, E; Schlotterbeck, G; Wettstein, JG | 1 |
1 other study(ies) available for amphetamine and rg 1678
Article | Year |
---|---|
Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia.
Topics: Amphetamine; Animals; CA1 Region, Hippocampal; Cell Line; Central Nervous System Stimulants; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Hallucinogens; Humans; Long-Term Potentiation; Mice; Motor Activity; Phencyclidine; Piperazines; Rats; Rats, Sprague-Dawley; Sulfones; Synaptic Transmission | 2012 |